Source disclosure: February 05, 2026
ZERIA PHARMACEUTICAL CO.,LTD. [4559.T]
TOKYO, Feb 17 (Pulse News Wire) – Zeria Pharmaceutical Co., Ltd. (4559.T) reported consolidated results for Q3 FY2026 (ending March 2026).
1 billion (-1.1% YoY). 57 billion (-16.4%). net profit attributable to shareholders was ¥5.55 billion (-32.5%).
8%. For the next fiscal year, the company forecasts 0 billion (+3.1%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms • Original filing💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.